MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0035887
Ritz Formulations Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.24 Cr
▲ 2% YoY
Net profit · FY 2025
₹35.7 Lakh
Net margin 5.7%
EBITDA · FY 2025
₹57.1 Lakh
EBITDA margin 9.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2.5 Lakh
Issued & subscribed
Open charges
₹2.18 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
About Ritz Formulations Private Limited
Data last updated:
Ritz Formulations Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Medico Intercontinental Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2019PTC106181. Its GSTIN is 24AAJCR3724Q1ZW (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.5 Lakh. It is led by directors including Samir Dilipkumar Shah and Dilipkumar Shah Bhogilal.
Its last annual general meeting (AGM) was held on 13 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 – Tf Adit Raj Arcade Nr. Karma Shreshtha Tower Satellite, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.24 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹35.7 Lakh (net margin 5.7%) and EBITDA of ₹57.1 Lakh (EBITDA margin 9.2%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹2.18 Cr on record. Court records list 2 cases involving the company, including 2 filed against it. The company has 1 deal on record (1 rights issue); the latest was in August 2020. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger; the largest is Cloverleaf Ecom Private Limited with revenue of ₹6.26 Cr. The company has 10 MSME Form 1 returns on record between 2019 and 2024, listing 3,347 overdue payments to 49 micro and small suppliers.
Ritz Formulations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0035887). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ritzpharma.com.
Company details
CIN U24230GJ2019PTC106181
Registration Number 106181
Incorporation Date 21 January 2019
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 13 June 2025
Date of Balance Sheet 31 March 2025
Parent Company Medico Intercontinental Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0035887
Key People
Samir Dilipkumar Shah Director Dilipkumar Shah Bhogilal Director Tanvi Samirbhai Shah Director Recognitions & Rankings of Ritz Formulations
Contact details
Ritz Formulations Private Limited's registered office is in Ahmedabad, Gujarat. Its website is ritzpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1 – Tf Adit Raj Arcade Nr. Karma Shreshtha Tower Satellite, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ritz Formulations Private Limited, buy the company report.
Comprehensive company report
Ritz Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ritz Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ritz Formulations Private Limited, buy the company report.
Financials of Ritz Formulations Private Limited
FY 2025 filings availableRitz Formulations Private Limited reported revenue of ₹6.24 Cr (up 2% YoY) for FY 2025.
Revenue · FY 2025
₹6.24 Cr ▲ 2%
Net profit · FY 2025
₹35.7 Lakh margin 5.7%
EBITDA · FY 2025
₹57.1 Lakh margin 9.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▼ 3%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 6%
5 years · compounded
▲ 7%
Revenue rose 2% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹57.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.2% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ritz Formulations Private Limited, buy the company report.
Board of directors of Ritz Formulations Private Limited
Ritz Formulations has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samir Dilipkumar Shah Also directs: Kings Marvela LLP, Medico Intercontinental Limited, Azillian Healthcare Private Limited and 5 more | Director | 21 Jan 2019 | 7 Years 9 Months | Current |
| Dilipkumar Shah Bhogilal Also directs: Kings Marvela LLP, Medico Intercontinental Limited, Azillian Healthcare Private Limited and 3 more | Director | 21 Jan 2019 | 7 Years 9 Months | Current |
| Tanvi Samirbhai Shah | Director | 12 Nov 2021 | 4 Years 11 Months | Current |
Peer comparison
Ritz Formulations Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cloverleaf Ecom Private Limited | ₹6.26 Cr (FY 2024) | -36.0% | Nagpur, Maharashtra, India | |||
| Sachio Pharma Bangalore Private Limited | ₹6.25 Cr (FY 2024) | -14.0% | Mumbai, Maharashtra, India | |||
| Solu Clinipharm Private Limited | ₹6.24 Cr (FY 2021) | -20.0% | Thane, Maharashtra, India | |||
| Ritz Formulations Private Limitedthis company | ₹6.24 Cr (FY 2025) | ₹35.7 Lakh | 5.7% | 2.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Ritz Formulations Private Limited, buy the company report.
Auditor
Ritz Formulations Private Limited is audited by B H MANGAROLIA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B H MANGAROLIA & CO. | FY 2023 | 105972W |
Shareholding
The shareholding of Ritz Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ritz Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.18 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Sep 2020 | 100369606 | Others | ₹1.09 Cr | Open | |
| 04 Sep 2020 | 100369599 | Others | ₹1.09 Cr | Open |
Total charge records: 2 View all charges
Deals & funding
Ritz Formulations Private Limited has 1 deal on record (1 rights issue); the latest was in August 2020.
Total deals
1
Rights issue
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2020 | Rights issue | ₹31.9 Lakh | Investors: Medico Intercontinental Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ritz Formulations Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company | Disposed |
To see the full case history of Ritz Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Ritz Formulations Private Limited has 10 MSME Form 1 returns on record between 2019 and 2024, listing 3,347 overdue payments to 49 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 49)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Medico Intercontinental Limited | |||
| Bajaj Formulations | |||
| Regency Health Care | |||
| Mas Pharmachem | |||
| Oxford Pharma |
To see the full MSME payment records of Ritz Formulations Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Ritz Formulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAJCR3724Q1ZW | Gujarat | Active | 23 Feb 2019 |
To see the full GST registrations and return filing status of Ritz Formulations Private Limited, buy the company report.
Recent activity
Ritz Formulations Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Tanvi Samirbhai Shah ceased to be Additional Director on 05 Sep 2022.
AGM
Ritz Formulations Private Limited last Annual general meeting of members was held on 13 Jun 2025 as per latest MCA records.
Filing
Ritz Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Tanvi Samirbhai Shah ceased to be Additional Director.
Appointed
Tanvi Samirbhai Shah was appointed as Director.
Charges
A charge with Others amounted to Rs. 109.00 Lakh with Charge ID 100369606 was registered on 11 Sep 2020.
Charges
A charge with Others amounted to Rs. 109.00 Lakh with Charge ID 100369599 was registered on 04 Sep 2020.
Appointed
Dilipkumar Shah Bhogilal was appointed as Director.
Appointed
Samir Dilipkumar Shah was appointed as Director.
Incorporation
21 Jan 2019
Ritz Formulations Private Limited was registered on 21 Jan 2019 with Roc Ahmedabad & aged 7 years 9 months as per MCA records.
Frequently asked questions
Ritz Formulations is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 January 2019 (7+ years old) and is registered under CIN U24230GJ2019PTC106181.
Ritz Formulations has 3 current directors:
- Samir Dilipkumar Shah - Director
- Dilipkumar Shah Bhogilal - Director
- Tanvi Samirbhai Shah - Director
The latest financial statements of Ritz Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 13 June 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Ritz Formulations is 24AAJCR3724Q1ZW, registered in Gujarat.
The CIN (Corporate Identification Number) of Ritz Formulations is U24230GJ2019PTC106181. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ritz Formulations has 2 court cases on record: 2 filed against it.
Ritz Formulations was incorporated on 21 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Ritz Formulations has 1 deal on record (1 rights issue); the latest was in August 2020.
The peers of Ritz Formulations by revenue are Cloverleaf Ecom Private Limited, Sachio Pharma Bangalore Private Limited, Solu Clinipharm Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Tanvi Samirbhai Shah ceased to be Additional Director on 05 Sep 2022. Tanvi Samirbhai Shah was appointed as Director on 12 Nov 2021. Dilipkumar Shah Bhogilal was appointed as Director on 21 Jan 2019. Ritz Formulations has 4 board changes on record in total.
Yes, Ritz Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0035887).
Ritz Formulations has 10 MSME Form 1 returns on record between 2019 and 2024, listing 3,347 overdue payments to 49 micro and small suppliers. The latest return was filed on 08 Apr 2024.